<DOC>
	<DOCNO>NCT02929888</DOCNO>
	<brief_summary>Prasugrel ticagrelor , new P2Y12-ADP receptor antagonist , associate great pharmacodynamic inhibition reduction cardiovascular event patient acute coronary syndrome . However , evidence lack effect achieve faster strong cyclooxygenase inhibition intravenous lysine acetylsalicylate ( LA ) compare oral aspirin prasugrel inhibit platelet . Recently , demonstrate healthy volunteer administration intravenous LA result significantly reduction platelet reactivity compare oral aspirin prasugrel inhibit platelet . Loading dose LA achieve platelet inhibition faster , great less variability aspirin . However , data issue patient ST-segment elevation myocardial infarction ( STEMI ) . The ECCLIPSE-STEMI trial study effect LA versus aspirin platelet reactivity patient STEMI</brief_summary>
	<brief_title>Study Platelet Function After Administration Aspirin Versus Lysine Acetylsalicylate STEMI Patients</brief_title>
	<detailed_description>This prospective , randomize , single-center , open platelet function study conduct 60 STEMI patient . Subjects randomly assign receive loading dose ( LD ) intravenous LA 450mg plus oral prasugrel 60mg/ticagrelor 180mg , LD aspirin 300mg plus prasugrel 60mg/ticagrelor 180mg orally . Platelet function evaluate baseline , 30 min , 1h , 4h , 24h use multiple electrode aggregometry vasodilator-stimulated phosphoprotein phosphorylation ( VASP ) . The primary endpoint study inhibition platelet aggregation arachidonic acid ( AA ) 1.5mM 30 min . Secondary endopoints inhibition platelet aggregation AA baseline 1h , 4h 24h , measurement aggregation platelet test ( ADP , collagen VASP ) .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Acetylsalicylic acid lysinate</mesh_term>
	<criteria>Aged &gt; 18 . Patients STsegment myocardial infarction . Signed write informed consent . Known allergy aspirin , clopidogrel , prasugrel ticagrelor . Cardiogenic shock hemodinamic instability . Recent antiplatelet therapy ( &lt; 14 day ) . Oral anticoagulation coumarin derivative . Any active bleeding blood dyscrasia . Recent gastrointestinal bleeding ( &lt; 6 month prior inclusion ) . Recent history stroke , TIA intracranial bleeding ( &lt; 6 month prior inclusion ) . Known anemia , trombopenia severe chronic kidney/liver disease Any known active neoplasm . Pregnant female .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>ST-segment elevacion myocardial infarction , platelet</keyword>
</DOC>